RONDOMYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Rondomycin patents expire, and when can generic versions of Rondomycin launch?
Rondomycin is a drug marketed by Medpointe Pharm Hlc and is included in one NDA.
The generic ingredient in RONDOMYCIN is methacycline hydrochloride. There are six drug master file entries for this compound. Additional details are available on the methacycline hydrochloride profile page.
Summary for RONDOMYCIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Patent Applications: | 5,471 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RONDOMYCIN at DailyMed |
US Patents and Regulatory Information for RONDOMYCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medpointe Pharm Hlc | RONDOMYCIN | methacycline hydrochloride | CAPSULE;ORAL | 060641-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Medpointe Pharm Hlc | RONDOMYCIN | methacycline hydrochloride | CAPSULE;ORAL | 060641-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Medpointe Pharm Hlc | RONDOMYCIN | methacycline hydrochloride | SYRUP;ORAL | 060641-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |